Home » Stocks » BIO.B

Bio-Rad Laboratories, Inc. (BIO.B)

Class B Shares
Stock Price: $605.65 USD 0.00 (0.00%)
Updated Jan 13, 2021 4:00 PM EST - Market closed
Market Cap 17.76B
Revenue (ttm) 2.29B
Net Income (ttm) 3.52B
Shares Out 5.09M
EPS (ttm) 116.69
PE Ratio 5.19
Forward PE 51.02
Dividend n/a
Dividend Yield n/a
Trading Day January 13
Last Price $605.65
Previous Close $605.65
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 574.15 - 605.65
Day's Volume 0
52-Week Range 324.07 - 642.05

News

Hide News
Investors Business Daily - 7 months ago

The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

Other stocks mentioned: BIO, QDEL, VEEV, VRTX
Zacks Investment Research - 1 year ago

The regulatory go-ahead is in line with Bio-Rad's (BIO) strategy of strengthening in the transfusion medicine market of the United States.

Zacks Investment Research - 1 year ago

The recent development will help Bio-Rad rake in increased top-line contributions from the Clinical Diagnostics business.

About BIO.B

Bio-Rad Laboratories develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are use... [Read more...]

Industry
Medical Devices
Founded
1952
CEO
Norman Schwartz
Employees
8,000
Stock Exchange
NYSE
Ticker Symbol
BIO.B
Full Company Profile